Harvard Medical School2d
Creating the World’s First CRISPR Medicine, for Sickle Cell Disease
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
FOX 29 Philadelphia on MSN1d
CHOP doctors named 'Disruptors of the Year' for groundbreaking sickle cell gene therapy
The Philadelphia Citizen is recognizing CHOP doctors Alexis Thompson and Dr. Stephan Grupp with the 'Disruptors of the Year' ...
Sickle cell disease is a genetic disorder that causes lifelong suffering—here's what you need to know
Right now, approximately 20 billion red blood cells are busy traveling through your blood vessels. They are delivering oxygen ...
Hosted on MSN7h
Advocating increased funding for sickle cell research: A call to action
Sickle cell disease is a severe, inherited blood disorder that primarily affects people of African, Mediterranean, Middle Eastern, and Indian descent.Despite its widespread impact, SCD research has ...
MUSC expands gene therapy, resources for Sickle Cell ‘warriors’ in South Carolina
The Medical University of South Carolina is expanding its access to state-supported Sickle Cell programs for “warriors,” or ...
Medscape10d
Sickle Cell Trait Widely Misinterpreted As Cause of Death
A new review and policy statement underscore the inaccuracy of sickle cell trait as a cause of death on autopsies.
WCIV Charleston on MSN3d
Gene therapy among cutting-edge treatments at MUSC's new sickle cell center in Charleston
The Medical University of South Carolina Health has established the Rena N. Grant Sickle Cell Center to help treat those ...
Health Affairs11d
An Agenda For Sickle Cell Disease Research That Encompasses Lived Experience
As treatment and care continues to evolve, we must ensure that people living with this disease are able to advocate for ...
Walsall sickle cell disease charity Plasma of Hope's creative workshop deluged with talented children
A Walsall charity which delivers vital help to those suffering with sickle cell disease is celebrating its fifth anniversary ...
'Groundbreaking' sickle cell treatment to be offered to NHS patients for first time
It is believed around 1,700 people could be eligible for the treatment, while the NHS estimates around 50 people a year will ...
High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.
The Punch on MSN14d
Understanding gallbladder issues in sickle cell patients
High bilirubin levels increase the risk of developing bilirubin gallstones—a type of gallstone more prevalent in Sickle Cell patients.